Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Indonesia
100%
Visual Acuity
42%
Meta-analysis
37%
Uveitis
36%
Systematic Meta-analysis
32%
Jakarta
30%
Intraocular Pressure
29%
Retinoblastoma
24%
Vitrectomy
22%
Leprosy
22%
Diabetic Retinopathy
21%
Blindness
21%
Left Eye
19%
Ocular Tuberculosis
18%
Proliferative Diabetic Retinopathy
18%
Cataract
18%
Pada
17%
Tuberculosis
16%
Dry Eye
15%
Glaucoma
15%
Visual Impairment
15%
Risk Factors
15%
Indonesian
15%
Clinical Manifestations
14%
Ophthalmologist
14%
Clinical Characteristics
14%
Glaucoma Patients
13%
Cornea
13%
COVID-19
13%
Cataract Surgery
13%
Anterior Uveitis
13%
Cytomegalovirus
12%
Best-corrected Visual Acuity
12%
Leprosy Patients
12%
Tumor
12%
Computed Tomography
11%
Causes of Blindness
11%
Intravitreal Bevacizumab
11%
Amniotic Membrane Transplantation
11%
Laser Photocoagulation
11%
Tears
11%
Phacoemulsification
10%
Eyelid
10%
Inflammation
10%
Retina
10%
Retinal Detachment
10%
Intravitreal
10%
Treatment Outcome
9%
Tubercular Uveitis
9%
Proptosis
9%
Rhegmatogenous Retinal Detachment
9%
Antitubercular Therapy
9%
Aldehyde Dehydrogenase 2 (ALDH2)
9%
Endophthalmitis
9%
Eye Drops
9%
Ocular Trauma
9%
Ocular Involvement
9%
Developing Countries
8%
Southwest Sumba
8%
Corticosteroids
8%
Vision Impairment
8%
Extraocular
8%
Right Eye
8%
Retinal pigment Epithelium
8%
Acute Primary Angle Closure
8%
Retinopathy of Prematurity
8%
Collaborative Ocular Tuberculosis Study
8%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
8%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
8%
Trauma
8%
Antiretroviral Therapy
8%
Myopia
7%
Visual Outcome
7%
COVID-19 Pandemic
7%
Severe Visual Impairment
7%
Ocular Inflammation
7%
PubMed
7%
Eye Hospital
7%
Clinical Outcomes
7%
Clinical Treatment
7%
Refractive Error
7%
Medical Records
7%
Retinal Vasculitis
7%
No Significant Difference
7%
Quantitative PCR
7%
Proliferative Vitreoretinopathy
6%
Levofloxacin
6%
Ocular Toxoplasmosis
6%
General Practitioners
6%
Conjunctival
6%
Infectious Uveitis
6%
Macular Edema
6%
General Hospital
6%
HIV Patients
6%
Pediatric
6%
Vision-related Quality of Life
6%
Odds Ratio
6%
Randomized Clinical Trial
6%
Diabetic Retinopathy Screening
6%
Diabetic Patients
6%
Medicine and Dentistry
Visual Acuity
51%
Systematic Review
49%
Uveitis
49%
Meta-Analysis
38%
Visual Impairment
35%
Intraocular Pressure
30%
Glaucoma
26%
Diseases
25%
Vitrectomy
24%
Eye Injury
24%
Cataract
24%
Ocular Tuberculosis
23%
Eye Disease
22%
Infection
20%
Cataract Surgery
19%
Neoplasm
19%
Retinoblastoma
18%
COVID-19
18%
Prevalence
17%
Diabetic Retinopathy
16%
Best Corrected Visual Acuity
16%
Cross Sectional Study
15%
Retinal Detachment
15%
Diabetes Mellitus
15%
Dry Eye
15%
Vasculotropin
13%
Vitreous
12%
Phacoemulsification
12%
Ophthalmology
12%
Pediatrics
12%
Laser Coagulation
12%
Recurrent Disease
11%
Bevacizumab
11%
Amnion
11%
Patient Referral
11%
Agents Acting on the Eye
10%
Proliferative Diabetic Retinopathy
10%
Retrospective Study
10%
Iridocyclitis
10%
Quality of Life
10%
Awareness
9%
Retinal Vasculitis
9%
Observational Study
9%
Retrospective Cohort Study
9%
Refractive Error
9%
Human Immunodeficiency Virus
9%
Implant
8%
Anterior Chamber of Eyeball
8%
Randomized Clinical Trial
8%
Medical Record
8%
Retinopathy of Prematurity
8%
Clinical Trial
8%
Polymerase Chain Reaction
8%
Malignant Neoplasm
7%
Exophthalmos
7%
Computer Assisted Tomography
7%
Contact Lens
7%
Cytomegalovirus
7%
Cancer
7%
Diplopia
7%
Optical Coherence Tomography
6%
Optic Nerve
6%
Ocular Surface
6%
Visual Field
6%
Stevens-Johnson Syndrome
6%
Lagophthalmos
6%
Corneal Ulcer
6%
Endophthalmitis
6%
LASIK
6%
Endocrine Ophthalmopathy
6%
Neovascular Glaucoma
6%
Pterygium Excision
6%
Carotid-Cavernous Fistula
6%
Adhesive Agent
6%
Antibiotics
6%
Iris
6%
Recurrence Risk
6%
Adverse Event
5%
Health Care Cost
5%
Ocular Toxoplasmosis
5%
Optic Neuropathy
5%
Foreign Body
5%
Biological Marker
5%
Disease
5%
Herpes Simplex Virus
5%
Iridotomy
5%
Pars Plana Vitrectomy
5%
Orbit Tumor
5%
Clinical Feature
5%
Pterygium
5%
Paracentesis
5%
Sarcoidosis
5%
Odds Ratio
5%
Magnetic Resonance Imaging
5%
Vitreous Hemorrhage
5%
Cell Density
5%
Ganglion
5%